Clinical Trial Update: Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating mesotherapy with minoxidil 0.5%/2 mL for female pattern alopecia, assessing efficacy and safety. Sponsor: Brasilia Univ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Female Pattern Hair Loss

Drugs mentioned

• MINOXIDIL (Minoxidil)

Snippet

Sponsor: Brasilia University Hospital | Conditions: Female Pattern Alopecia | Phase 3 | Status: UNKNOWN